Enalapril reduced the risk for new-onset diabetes in left ventricular dysfunction
- Enalapril reduced the risk for new-onset diabetes in left
ventricular dysfunction: COMMENTARY. Gerstein, Hertzel // ACP Journal Club;Nov/Dec2003, Vol. 139 Issue 3, p68
Dysglycemic states, including diabetes, impaired glucose tolerance, and lesser degrees of hyperglycemia, are risk factors for subsequent cardiovascular (CV) events. Moreover, non-diabetic patients at high risk for future CV events are likely to be dysglycemic and have a high risk for future...
- ERRATA. // Diabetes;Apr2010, Vol. 59 Issue 4, p1113
Two corrections to the articles "Reduction of the Accumulation of Advanced Glycation End Products by ACE Inhibition in Experimental Diabetic Nephropathy" and "Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy" published in the periodical "Diabetes" are presented.
- Less Is More. Stanton, Robert C. // Diabetes Health;Oct2005, Vol. 14 Issue 10, p20
Provides information on standard and treatment for type 1 and type 2 diabetes. Standard level of blood glucose released by the American Association of Clinical Endocrinologists; Mechanism of action of angiotensin-converting enzyme and angiotensin receptor blockers in diabetics.
- Angiotensin-Converting—Enzyme Inhibitors for Impaired Glucose Tolerance – Is There Still Hope? Ingelfinger, Julie R.; Solomon, Caren G. // New England Journal of Medicine;10/12/2006, Vol. 355 Issue 15, p1608
The author talks about the use of angiotensin-converting enzyme (ACE) inhibitors to prevent or delay the onset of impaired glucose intolerance or diabetes. According to the author, diet and exercise also reduce the risk to develop diabetes. According to the author, several randomized control...
- Increased tubular organic ion clearance following chronic ACE inhibition in patients with type 1 diabetes. Thomas, Merlin C.; Jerums, George; Tsalamandris, Con; MacIsaac, Richard; Panagiotopoulos, Sianna; Cooper, Mark E. // Kidney International;Jun2005, Vol. 67 Issue 6, p2494
Increased tubular organic ion clearance following chronic ACE inhibition in patients with type 1 diabetes.Background.The tubular excretion of creatinine significantly contributes to its clearance. Administration of an angtiotensin-converting enzyme (ACE) inhibitor is associated with increased...
- ACE in the hole. Luft, Friedrich // Journal of Molecular Medicine;Aug2014, Vol. 92 Issue 8, p793
An introduction to the journal is presented in which the author discusses articles about angiotensin-converting enzyme-2 (ACE2), an exopeptidase.
- Diabetic Kidney Disease: Act Now or Pay Later. Atkins, Robert C.; Zimmet, Paul // Archives of Iranian Medicine (AIM);Jan2010, Vol. 13 Issue 1, p77
The article provides information and therapeutics of diabetic kidney disease in the U.S. It states that diabetes is a major cause of end kidney failure throughout the world in both developed and emerging nations. It infers that the disease could be treated using an angiotensin converting enzyme...
- Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition. Wihler, C.; Schäfer, S.; Schmid, K.; Deemer, E. K.; Münch, G.; Bleich, M.; Busch, A. E.; Dingermann, T.; Somoza, V.; Baynes, J. W.; Huber, J. // Diabetologia;Aug2005, Vol. 48 Issue 8, p1645
Aims/hypothesis: Renal accumulation of AGEs may contribute to the progression of diabetic nephropathy. We evaluated the effect of ramipril (a pure ACE inhibitor) and AVE7688 (a dual inhibitor of ACE and neutral endopeptidase) on renal accumulation of the advanced glycation end-product (AGE)...
- ACE inhibitors reduce all-cause mortality in diabetic nephropathy; data unclear for AIIRAs. // Formulary;Mar2005, Vol. 40 Issue 3, p91
This article reports that a meta-analysis demonstrates that angiotensin converting enzyme (ACE) inhibitors provide a survival benefit in patients with diabetic nephropathy, whereas no such evidence exists for angiotensin II receptor antagonists (AIIAs). Both classes of drugs prevent progression...